Monitoring antiepileptic drugs: A level-headed approach

Current Neuropharmacology

Volumn 7, Issue 2, 2009, Pages 115-119

  St Louis, Erik K ^a  

^a MAYO CLINIC   (United States)

Author keywords

Antiepileptic drugs; Blood levels; Epilepsy; Monitoring

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CARBAMAZEPINE 10,11 OXIDE; ETHOSUXIMIDE; ETIRACETAM; FELBAMATE; GABAPENTIN; HARKOSERIDE; ILLICIT DRUG; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; RUFINAMIDE; TIAGABINE; TOPIRAMATE; VALPROIC ACID; ZONISAMIDE;

AGING; DRUG ABUSE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG METABOLISM; DRUG MONITORING; DRUG SAFETY; DRUG TOLERABILITY; DRUG UTILIZATION; EPILEPSY; HEALTH STATUS; HUMAN; MEDICAL DECISION MAKING; PATIENT ATTITUDE; PATIENT COMPLIANCE; PHYSICIAN ATTITUDE; POLYPHARMACY; PREGNANCY; QUALITY OF LIFE; REVIEW; SLEEP DISORDER; UNSPECIFIED SIDE EFFECT;

EID: 70349705741     PISSN: 1570159X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157015909788848938     Document Type: Review

References (14)

1. Booker, H.E. (1972) Phenobarbital, mephobarbital, and metharbital: relation of plasma levels to clinical control. in Antiepileptic Drugs; (Woodbury, D.M., Penry, J.K., Schmidt, R.P. Eds.) Raven Press; New York, pp. 329-334.
2. Chadwick, D. (1987) Overuse of monitoring of blood concentrations of antiepileptic drugs. BMJ, 294, 723-724.
3. Gilliam, F.G., Fessler, A.J., Baker, G., Vahle, V., Carter, J., Attarian, H. (2004) Systematic screening allows reduction of adverse antiepileptic drug effects: a randomized trial. Neurology, 62(1), 23-27.
4. Januzzi, G., Cian, P., Fattore, C., Gatti, G., Bartoli, A., Monaco, F., Perucca, E. (2000) A multicenter randomized controlled trial on the clinical impact of therapeutic drug monitoring in patients with newly diagnosed epilepsy. The Italian TDM Study Group in Epilepsy. Epilepsia, 41(2), 222-230.
5. Kwan, P., Brodie, M.J. (2001) Effectiveness of first antiepileptic drug. Epilepsia, 42(10), 1255-1260.
6. Larkin, J.G., Herrick, A.L., McGuire, G.M., Percy-Robb, I.W., Brodie, M.J. (1991) Antiepileptic drug monitoring at the epilepsy clinic: a prospective evaluation. Epilepsia, 32, 89-95.
7. Lesser, R.P., Pippenger, C.E., Luders, H., Dinner, D.S. (1984) High dose monotherapy in treatment of intractable seizures. Neurology, 34, 707-711.
8. Schoenenberger, R.A., Tanasijevic, M.J., Jha, A., Bates, D.W. (1995) Appropriateness of antiepileptic drug monitoring. JAMA, 274, 1622-1626.
9. Sherwin, A.I., Robb, J.P. (1972) Ethosuximide: relation of plasma levels to clinical control. in Antiepileptic Drugs; (Woodbury, D.M., Penry, J.K., Schmidt, R.P. Eds.) Raven Press; New York, pp. 443-448.
10. Sherwin, A.I., Robb, J.P., Lechter, M. (1973) Improved control of epilepsy by monitoring ethosuximide. Arch. Neurol. (Chic), 28, 178-181.
11. Theodore, W.H. (1992) Rational use of antiepileptic drug levels. Pharmacol. Ther., 54, 297-305.
12. Willmore, L.J. (2002) Safety monitoring of antiepileptic drugs. in Antiepileptic Drugs; (Levy, R.H., Mattson, R.H., Meldrum, B.S., Perucca, E. Eds.) 5th ed. Lippincott Williams and Wilkins, pp. 112-118.
13. Woo, E., Chan, Y.M., Yu, Y.L., Chan, Y.W., Huang, C.Y. (1988) If a well-stabilized epileptic patient has a subtherapeutic antiepileptic drug level, should the dose be increased? A randomized prospective study. Epilepsia, 29, 129-139.
14. Yahr, M.D., Sciarra, D., Carter, S., Merritt, H.H. (1952) Evaluation of standard anticonvulsant therapy in three hundred nineteen patients. J. Am. Med. Assoc., 150, 663-667.